307 related articles for article (PubMed ID: 37047357)
21. Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Iannone F; Semeraro A; Carlino G; Santo L; Bucci R; Quarta L; Maruotti N; Zuccaro C; Marsico A; Falappone PCF; Mazzotta D; Cantatore FP; Muratore M; Lapadula G
Clin Drug Investig; 2019 Jun; 39(6):565-575. PubMed ID: 30941736
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of psoriatic arthritis therapies.
Gladman DD
Semin Arthritis Rheum; 2003 Aug; 33(1):29-37. PubMed ID: 12920694
[TBL] [Abstract][Full Text] [Related]
23. Major differences in medical and surgical treatment of psoriatic arthritis and rheumatoid arthritis: a comparison of two historic cohorts.
Nystad TW; Fenstad AM; Fevang BT
Scand J Rheumatol; 2020 Jul; 49(4):267-270. PubMed ID: 32757727
[TBL] [Abstract][Full Text] [Related]
24. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
Orsolini G; Bertoldi I; Rossini M
Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
[TBL] [Abstract][Full Text] [Related]
25. Early arthritis clinic is effective for rheumatoid and psoriatic arthritides.
Nisar MK
Rheumatol Int; 2019 Apr; 39(4):657-662. PubMed ID: 30783800
[TBL] [Abstract][Full Text] [Related]
26. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Benucci M; Gobbi FL; Guiducci S; Foti R; Mosca M; Goletti D
Semin Arthritis Rheum; 2017 Oct; 47(2):183-192. PubMed ID: 28413099
[TBL] [Abstract][Full Text] [Related]
27. Clinical remission in rheumatoid arthritis and psoriatic arthritis.
Lubrano E; Mesina F; Caporali R
Clin Exp Rheumatol; 2018; 36(5):900-910. PubMed ID: 29600949
[TBL] [Abstract][Full Text] [Related]
28. Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment.
Conigliaro P; Triggianese P; Perricone C; Chimenti MS; Di Muzio G; Ballanti E; Guarino MD; Kroegler B; Gigliucci G; Grelli S; Perricone R
Clin Exp Immunol; 2014 Jul; 177(1):234-43. PubMed ID: 24666401
[TBL] [Abstract][Full Text] [Related]
29. Peripheral arthritis in psoriatic arthritis: from immunopathogenesis to therapy with Janus kinase inhibitors.
Ciccia F; Crispino N
Clin Exp Rheumatol; 2023 Jan; 41(1):170-176. PubMed ID: 36622097
[TBL] [Abstract][Full Text] [Related]
30. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D
RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353
[TBL] [Abstract][Full Text] [Related]
31. Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis.
Haberhauer G; Strehblow C; Fasching P
Wien Med Wochenschr; 2010 May; 160(9-10):220-4. PubMed ID: 20632149
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept.
Picchianti-Diamanti A; Germano V; Ferlito C; Migliore A; D'Amelio R; Laganà B
Qual Life Res; 2010 Aug; 19(6):821-6. PubMed ID: 20373036
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.
Michelsen B; Uhlig T; Sexton J; van der Heijde D; Hammer HB; Kristianslund EK; Wierød A; Bakland G; Rødevand E; Krøll F; Loge JH; Haugeberg G; Kvien TK
Ann Rheum Dis; 2018 Sep; 77(9):1290-1294. PubMed ID: 29875096
[TBL] [Abstract][Full Text] [Related]
34. Biological Treatment Patterns in Patients with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up.
Cañete JD; Naranjo A; Calvo J; Ordás C; Aragón B; Nocea G; Roset M; Fernández-Nebro A
Reumatol Clin (Engl Ed); 2020; 16(6):447-454. PubMed ID: 30704919
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
[TBL] [Abstract][Full Text] [Related]
36. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.
Amital H; Barak V; Winkler RE; Rubinow A
Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480
[TBL] [Abstract][Full Text] [Related]
37. Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.
Behrens F; Koehm M; Schwaneck EC; Schmalzing M; Wittig BM; Gnann H; Greger G; Tony HP; Burkhardt H
Scand J Rheumatol; 2019 Sep; 48(5):375-382. PubMed ID: 31311386
[No Abstract] [Full Text] [Related]
38. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D;
Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440
[TBL] [Abstract][Full Text] [Related]
39. TCD4
Picchianti Diamanti A; Laganà B; Cox MC; Pilozzi E; Amodeo R; Bove M; Markovic M; Di Rosa R; Salemi S; Sorgi ML; Rosado MM; D'Amelio R
J Transl Med; 2017 Feb; 15(1):38. PubMed ID: 28222785
[TBL] [Abstract][Full Text] [Related]
40. High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry.
Fornaro M; Righetti G; Abbruzzese A; Lopalco G; Cacciapaglia F; Anelli MG; Venerito V; Iannone F
Clin Rheumatol; 2021 Sep; 40(9):3659-3665. PubMed ID: 33864158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
